9 May 2022 -
SHS strengthens finance team: Lukas Maucher joins Tübingen-based private equity investor as CFO
Before joining SHS, Lukas worked as a manager at one of the Big Four auditing firms in southern Germany. He completed his Bachelor of Science in Business Administration with a focus on Corporate Accounting and Finance at the LMU in Munich. He completed his Master’s degree at the University of Mannheim with a focus on Accounting & Taxation.
Lukas is looking forward to his role at the sector specialist: “I am looking forward to the challenge of working for one of Europe’s leading healthcare investors in the areas of investor relations, fund controlling and transaction financing.”
Hubertus Leonhardt, Managing SHS Partner elaborates: “We expect transaction business and fund volumes to continue to increase in the coming years. We are very pleased to have Lukas join our finance team and welcome him.”
SHS plans to close further transactions in the healthcare sector in the coming quarters. The focus will be on minority and majority investments in growth companies and successions. For example, one of the new additions from the last quarters is the medium-sized Lowenco A/S, which specialises in ultra-low temperature storage solutions. Recent exits include, for example, the sale of c-LEcta, a leading enzyme manufacturer based in Leipzig, and phenox GmbH, a medical technology company based in Bochum with a focus on stroke therapy.